# L-glutamine Treatment in Patients With Diverticulosis

> **NCT05106101** · PHASE1 · COMPLETED · sponsor: **Emmaus Medical, Inc.** · enrollment: 9 (actual)

## Conditions studied

- Diverticulosis, Colonic

## Interventions

- **DRUG:** L-glutamine

## Key facts

- **NCT ID:** NCT05106101
- **Lead sponsor:** Emmaus Medical, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-19
- **Primary completion:** 2022-12-30
- **Final completion:** 2022-12-30
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2023-02-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05106101

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05106101, "L-glutamine Treatment in Patients With Diverticulosis". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05106101. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*